Pharma

Intra-Cellular Therapies (Nasdaq: ITCI) is a drug-development company developing novel therapeutics for depression, schizophrania, Parkinson’s disease, Alzheimer’s disease, and other Central Nervous System (CNS) disorders.

Indevus Pharmaceuticals is a publicly-traded biotechnology company focusing on developing and commercializing speciality pharmaceuticals. Through internal R&D and strategic partnerships, it is advancing the state-of-art

Colby Pharmaceuticals acquired Othera Pharmaceuticals in September 2012. Colby is a clinical company developing proprietary drug molecules targeting diseases related to oxidative stress, immunity, cancer,